Stage Iii Esophageal Cancer: Disease Bioinformatics
Esophageal cancers typically begin in the bottom portion of the esophagus, and affect more men than women. The cancer is typically diagnosed at a late stage, so it has a relatively poor prognosis. There are two types of esophageal cancer: squamous cell carcinoma and adenocarcinoma. Risk factors include: older age, poor diet, drinking alcohol, obesity, gastroesophageal reflux disease, smoking, chewing tobacco, and radiation treatment to the chest or upper abdomen. It is not a very common cancer in the United States, but it has higher incidence rates in places like Asia and Africa. Treatments include surgery, chemotherapy, radiation, and clinical trials. In stage III of esophageal cancer, the cancer has spread to the inner muscle layer of the connective tissue wall, and may have localized beyond the esophagus into nearby or distant organs, tissues, and lymph nodes. Stage III is considered an agressive stage of cancer and is difficult to treat.
Stage Iii Esophageal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Esophageal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1291 products for the study of Stage Iii Esophageal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.